Skip to main content

NCI SBIR Workshop on Federal Resources to Accelerate Commercialization 2013

May 7, 2013

NCI Shady Grove Campus Rockville, MD

Add to Outlook Calendar

Event Overview

On May 7, the NCI SBIR Development Center hosted a free one-day workshop on Federal Resources to Accelerate Commercialization. This workshop represented NCI SBIR’s latest efforts to move funded technologies from bench to bedside and was hosted to inform NCI SBIR & STTR awardees about the various federal resources and processes pivotal to the commercialization and clinical adoption of cancer technologies. The workshop presented an opportunity for nearly 200 attendees to share experiences and learn from the challenges and successes of other SBIR & STTR awardees. The workshop included opportunities for one-on-one meetings with representatives of many of the presenting federal organizations as well as the NCI SBIR Program Directors.


Workshop Highlights

Experts at the Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS), the Office of Science & Technology Policy (OSTP), and the United States Patent and Trade Office (USPTO) discussed regulatory approval processes, policies on coverage reimbursement for new medical technologies, collaboration across the federal government, and special intellectual property resources for small businesses.

A panel session featured other sources of federal funding, including the Congressionally Directed Medical Research Programs Exit Disclaimer (CDMRP) at the Department of Defense Exit DisclaimerNational Science Foundation (NSF), and the Biomedical Advanced Research and Development Authority (BARDA).

Resources and collaborative programs at NIH were presented by representatives with the NCI Experimental Therapeutics Program (NExT), Clinical Assay Development Program (CADP), PREVENT Cancer Preclinical Drug Development ProgramFrederick National Lab for Cancer Research and programs at the National Center for Advancing Translational Sciences (NCATS).

A panel discussion, moderated by David Parkinson of New Enterprise Associates (NEA), focused on how cancer startups can achieve success in today's financing climate and industry framework. The panel included representatives of unique life science investment organizations and past SBIR/STTR recipients, who shared experiences and discussed their personal challenges and successes as SBIR & STTR awardees.

Networking breaks and a networking lunch allowed for over 150 one-on-one meetings with experts from presenting federal organizations and other attendees.

If you have any questions about this workshop, please contact the NCI SBIR Development Center at